Eric Langewisch is a Nephrology physician affiliated with University of Nebraska at Omaha. OpenAlex indexes 19 publications with 340 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20254 paymentsResearch$21,818openpaymentsdata.cms.gov ↗
- Biogen, Inc.Program year20251 payment
- CSL BehringProgram year20247 paymentsResearch$21,296openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.3%Beta blocker17.3%Carvedilol69%Metoprolol Tartrate17%Metoprolol Succinate9%Propranolol Hcl6%Part D<11 patientsCalcium channel blocker10.4%Nifedipine Er60%Amlodipine Besylate40%Part D≥30 patients+ 8 more classes in this area
Metabolism & gastrointestinal
35.3%Corticosteroid22.5%Prednisone100%Part D≥100 patientsProton pump inhibitor7.6%Pantoprazole Sodium67%Omeprazole33%Part D≥26 patients+ 2 more classes in this area
Anti-infectives
3.6%Short-acting sulfonamides2.7%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor0.9%Valganciclovir Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Tacrolimus Trough Intra-Patient Variability on Donor Derived Cell-Free DNA and Clinical Outcomes
American Journal of Transplantation
2026 - Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation
Journal of the American Society of Nephrology
2026 - Successful Living Related Kidney Transplant Alone in a Patient with Noncirrhotic Portal Hypertension
Journal of the American Society of Nephrology
2025 - Impact of Induction Therapy on Infectious Complications in Simultaneous Liver-Kidney Transplant Recipients
American Journal of Transplantation
2025 - Kidney Transplant Candidacy: Addressing Common Medical and Psychosocial Barriers to Transplant
Advances in Kidney Disease and Health
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Karnegis, MD
University of Nebraska at Omaha
Jason Johanning, MD
University of Nebraska at Omaha
Iraklis Pipinos, MD
University of Nebraska at Omaha
Jasmine Marcelin, MD
University of Nebraska at Omaha
Laura Svetkey, MD
Duke University
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Rajesh V. Thakker
Queen Mary University of London
Paul Kimmel, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”